KUALA LUMPUR, Dec 7 (Bernama) -- Aptorum Group Ltd announced today that its proposed initial public offering (IPO) of Class A Ordinary Shares at US$15.80 per share (US$1 = RM4.16) to raise US$30 million was declared effective by the US Securities and Exchange Commission (SEC) on Dec 3.
The Hong Kong-based pharmaceutical company dedicated to developing and commercialising therapeutic projects and diagnostic technologies to tackle unmet medical needs is offering up to 1,898,734 shares and up to 51,990 underwriter warrants, while certain selling shareholders are offering up to 1,595,235 shares.
The shares are expected to begin trading on the NASDAQ Global Market on Dec 18 under the symbol APM with the offering expected to close on or before Dec 12.
The offering will be sold on a best-efforts basis. Boustead Securities, LLC, China Renaissance Securities (HK) Ltd and AMTD Global Markets Ltd are acting as co-underwriters for the offering.
The offering is made only by means of a written prospectus forming part of the effective registration statement. A copy of the prospectus may be obtained for free by visiting EDGAR on the SEC's website at www.sec.gov.
For more information, visit www.aptorumgroup.com
-- BERNAMA
No comments:
Post a Comment